Cell Therapeutics, Inc. Company Information
Overview
Cell Therapeutics, Inc. mainly operate in the Home Health Care Services industry. Currently they have estimated 400 employees.
Website:
- http://www.ctibiopharma.com
Size:
-
400 employees
Phone Number:
-
Fax
Industry:
-
Home Health Care Services
Founded:
-
1992
Employees at Cell Therapeutics, Inc.
Showing 10 of 399| JOB TITLE | WORK EMAIL | WORK PHONE | LOCATION | |
|---|---|---|---|---|
| Executive Vice President, General Counsel and Corporate Secretary / Senior Consultant | Leigh, Gloucestershire | |||
| Senior Manager Of Api Manufacturing | Boise, Idaho | |||
| Employee | Seattle, Washington | |||
| Director Clinical Development and Portfolio Management | New York, New York | |||
| Vice President, Information Technology | Seattle, Washington | |||
| Associate Director, President and Ceo ' S Office | Seattle, Washington | |||
| Director, Corporate Systems and It Consultant | Scottsdale, Arizona | |||
| President | Seattle, Washington | |||
| Vice President Business Development | Seattle, Washington | |||
| Employee | Seattle, Washington |
Executive Vice President, General Counsel and Corporate Secretary / Senior Consultant
Leigh, Gloucestershire Senior Manager Of Api Manufacturing
Boise, Idaho Employee
Seattle, Washington Director Clinical Development and Portfolio Management
New York, New York Vice President, Information Technology
Seattle, Washington Associate Director, President and Ceo ' S Office
Seattle, Washington Director, Corporate Systems and It Consultant
Scottsdale, Arizona President
Seattle, Washington Vice President Business Development
Seattle, Washington Employee
Seattle, Washington Enter an employee name to search and verify work emails, phone numbers and social links etc.
Cell Therapeutics, Inc.'s Email Format
We found 3 email formats used by Cell Therapeutics, Inc. employees. The most common Cell Therapeutics, Inc. email format is first_initial last ex.(jdoe@ctibiopharma.com) being used 89% of the time.
first_initial last
89%
first.last
7%
others
4%